Related Experiment Video
Updated: Apr 29, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated
Abstract:
Oncogene-induced senescence (OIS) is an initial barrier to tumor development. Reactive oxygen species (ROS) is critical for oncogenic Ras OIS, but the downstream effectors to mediate ROS signaling are still relatively elusive. Senescent cells develop a senescence-associated secretory phenotype (SASP). However, the mechanisms underlying the regulation of the SASP are largely unknown. Here, we identify protein kinase D1 (PKD1) as a downstream effector of ROS signaling to mediate Ras OIS and SASP. PKD1 is activated by oncogenic Ras expression and PKD1 promotes Ras OIS by mediating inflammatory cytokines interleukin-6 (IL-6) and interleukin-8 (IL-8) via modulation of NF-κB activity. We demonstrate that ROS-protein kinase Cδ (PKCδ)-PKD1 axis is essential for the establishment and maintenance of IL-6/IL8 induction. In addition, ablation of PKD1 causes the bypass of Ras OIS, and promotes cell transformation and tumorigenesis. Together, these findings uncover a previously unidentified role of ROS-PKCδ-PKD1 pathway in Ras OIS and SASP regulation.
Insights
Protein kinase D1 (PKD1) is a key mediator of oncogene-induced senescence (OIS) and the senescence-associated secretory phenotype (SASP). This study reveals the ROS-PKCδ-PKD1 pathway is crucial for OIS and SASP, impacting tumor development.
Area of Science:
- Cellular senescence
- Oncogenesis
- Signal transduction pathways
Background:
- Oncogene-induced senescence (OIS) acts as a tumor suppressor mechanism.
- Reactive oxygen species (ROS) are critical for OIS, but downstream signaling is unclear.
- The senescence-associated secretory phenotype (SASP) is characteristic of senescent cells, with regulatory mechanisms largely unknown.
Purpose of the Study:
- To identify downstream effectors of ROS signaling in oncogenic Ras-induced senescence (OIS).
- To elucidate the mechanisms regulating the senescence-associated secretory phenotype (SASP).
- To investigate the role of Protein Kinase D1 (PKD1) in OIS and SASP.
Main Methods:
- Investigated the activation of PKD1 by oncogenic Ras expression.
- Analyzed the role of PKD1 in mediating inflammatory cytokines (IL-6, IL-8) via NF-κB modulation.
- Examined the ROS-protein kinase Cδ (PKCδ)-PKD1 axis in OIS and SASP establishment.
- Assessed the consequences of PKD1 ablation on Ras OIS, cell transformation, and tumorigenesis.
Main Results:
- Protein kinase D1 (PKD1) was identified as a downstream effector of ROS signaling in Ras-induced OIS.
- PKD1 activation by oncogenic Ras promotes OIS and SASP by regulating IL-6 and IL-8 through NF-κB.
- The ROS-PKCδ-PKD1 pathway is essential for IL-6/IL-8 induction and SASP maintenance.
- Ablation of PKD1 bypassed Ras OIS, promoting cell transformation and tumorigenesis.
Conclusions:
- PKD1 is a critical mediator of ROS signaling in oncogene-induced senescence (OIS).
- The ROS-PKCδ-PKD1 pathway plays a vital role in regulating the senescence-associated secretory phenotype (SASP).
- This pathway is a key determinant in preventing tumor development by promoting OIS and SASP.
More Related Videos
Related Concept Videos
The Ras Gene
Ras is a...
PI3K/mTOR/AKT Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Abnormal Proliferation

